Somatostatin receptor (SSTR) imaging is widely used for guiding the management of
neuroendocrine tumor (NET) patients. Ga-DOTATATE approval by the US Food and Drug …

… Somatostatin receptors (SSTRs) are variably expressed by a variety of malignancies. Using
radiolabeled somatostatin … imaging and for peptide receptor radionuclide therapy. In-DTPA-…

… At time of SSTR-directed PET/CT, calcitonin was median 1400 pg/ml (range, 26–42700) …
Upon referral by the treating physician, all patients underwent SSTR-directed PET/CT due to …

… Somatostatin receptor (SSTR) PET has demonstrated a … in the appropriate use of SSTR PET
for imaging of patients with … of NET seen predominantly on SSTR PET, evaluation of patients …

… GaTate PET/CT allows whole-body imaging of cell surface expression of somatostatin receptors
… patients to curative surgery by identifying a primary tumor site and directing patients with …

Background Somatostatin receptor (SSTR)–targeted PET/CT is used for patients affected
with small cell lung cancer (SCLC), but the clinical impact has not been elucidated yet. We …

… Our results further support the concept of somatostatin receptor directed PET imaging as
a readout of macrophage infiltration within areas of inflamed and/or damaged myocardium. …

… 68 Ga-DOTANOC and 18 F-FDG PET/CT has demonstrated encouraging diagnostic accuracy
for SSTR-directed PET, the prognostic value of 68 Ga-DOTATOC PET/CT, especially in …

… analogues also are being investigated for somatostatin receptor-directed radiotherapy treatment
… Similar to PETs, 85–100% of carcinoid tumours possess somatostatin sst 2 and/or sst 5 …

… PET shows a significantly higher detection rate compared with conventional somatostatin
receptor … is an excellent method for screening of tumor lesions followed by a more directed CT. …